scorecardresearch
Follow Us:
Tuesday, July 05, 2022

Anil Sasi

Profile

Anil Sasi is National Business Editor with the Indian Express and writes on business and finance issues. He has worked with The Hindu Business Line and Business Standard and is an alumnus of Delhi University.

Explained: What does Lina Khan’s appointment indicate for antitrust policy in US, elsewhere?
Thu, Jun 17, 2021

Lina Khan, 32, President Joe Biden's choice to lead the US competition regulator, wrote a seminal critique of Amazon's business practices four years ago, and is one of America's most prominent critics of the power of Big Tech. What does her appointment indicate for antitrust policy in the US and elsewhere?

WhatsApp vs Govt: in two cases in HC, each side contradicts itself
Mon, Jun 07, 2021

While WhatsApp wants the new rules quashed, the Centre has argued that the rules pertaining to tracking the first originator are an example of “reasonable restriction” to which the “fundamental right to privacy is subject”.

Explained: What the G7 corporate tax deal means for India
Tue, Jun 08, 2021

The deal announced Saturday involving the US, the UK, Germany, France, Canada, Italy and Japan, is likely to be put before a G20 meeting in July.

Powered by sale of utility vehicles in May, Hyundai duo beat Suzuki for the first time
Thu, Jun 03, 2021

Hyundai Motor India, alongside group company Kia Motors, accounted for one in every three vehicles sold in April in the highly-competitive UV market.

Centre looks to finetuning vaccine strategy: studying single-shot effect to mixing doses
Mon, May 31, 2021

Covishield, which is the main Covid vaccine in use in India, accounts for nearly 90 per cent of the 208.89 million doses administered since January 16.

Uday Kotak: ‘Time for state to get more active; strongly in favour of fiscal support’
Thu, May 27, 2021

He said if we can vaccinate a larger percentage of people and move our vaccination to around 15 crore a month by August — that rate would start providing the comfort on gradual opening up thereafter.

Explained: The Fed Reserve’s plan for cryptocurrencies, and why it is significant
Thu, May 27, 2021

The US Federal Reserve is going to issue a paper shortly that will focus on the benefits and risks of a central bank digital currency, seeking public comment on whether it should go ahead with the plan and flagging the risks etc.

2-DG holds promise but need more data before use: Experts
Thu, May 20, 2021

2DG hasn’t been launched in the market and the price of the sachet hasn’t been announced. Many experts have flagged concerns over the approval.

Short-supply Covid vaccines outliers in govt’s spirited price cap push
Sun, May 16, 2021

India currently has just two Covid-19 vaccines in what is clearly a market overwhelmingly dominated by just one player.

‘India needs policy-change reforms’
Sat, May 15, 2021

He cautioned, “India is de-globalising, not back to what it was before but more than the world is; owing to policy choices: increased protection and decreased attention to export competitiveness.”

Vaccine inequity gets worse: rural India, smaller hospitals hit
Tue, May 11, 2021

In the guidelines for the “Liberalised and Accelerated Phase 3 Strategy of Covid-19 Vaccination”, the Centre mandated prior online registration on the CoWin portal for the 18-44 years age group.

Covid infects ATC, power grid ops as staff, kin fall sick
Mon, May 03, 2021

Officials at POSOCO — India’s electricity grid manager — have alluded to a “worrying shortage” of operators, including those manning some control rooms.

What rate card does not show: Govt help in developing Covaxin
Wed, Apr 28, 2021

According to Bharat Biotech, the firm will supply more than 50 percent of its production to the Centre at Rs 150 a dose. The higher rates for States and private hospitals are necessitated by its needs to fund R&D for other vaccines, the company said.

Serum Institute’s Rs 600/dose for Covishield in private hospitals is its highest rate the world over
Sun, Apr 25, 2021

This, despite it being contract-manufactured by Pune’s Serum Institute of India whose CEO Adar Poonawalla had said that the firm was making a profit even at a price of Rs 150 per dose.

Before ramp-up, vaccine planning on the fly with only 2 options in basket
Thu, Apr 22, 2021

India has largely been reliant on a real-time supply of vaccines from essentially a duopoly of suppliers.

Margrethe Vestager: ‘Need to become better at analysing non-monetary payment and role of data’
Mon, Apr 19, 2021

It is my firm belief based on my experience and the history of competition law enforcement that if you have competition, then you also have a more prosperous and a dynamic economy.

Explained: Despite not being a policy tool, why the WPI surge is worrying
Tue, Apr 20, 2021

The WPI data comes right after the retail (CPI) inflation scaled a four-month peak of 5.52 per cent in March.

Door for global vaccines opens but pricing strategy could be key to entry
Wed, Apr 14, 2021

The NDA government is learnt to have negotiated the cost of Covishield — Serum Institute of India’s (SII) version of the AstraZeneca-University of Oxford vaccine -- to Rs 150 plus GST, or around $2.02, per dose.

Explained: Joe Biden’s radical tax proposal
Sat, Apr 10, 2021

US Treasury Secretary Janet Yellen has urged G20 nations to move towards a global minimum corporate tax. What can this mean for India, other economies, and corporations that benefit from low-tax regimes?

Localised lockdowns in second wave set to hit services recovery
Thu, Apr 01, 2021

High frequency indicators have begun to reflect some moderation due to administrative clampdown in a bunch of districts including Maharashtra and Gujarat.

Explained: How Google Maps plans to nudge you towards the greenest route to your destination
Thu, Apr 01, 2021

Google Maps plans to start highlighting journeys and directing drivers to routes that it calibrates to be the most "eco-friendly" based on a range of factors. Here's how it will work.

Explained: How and why Covid-19 disrupted production of automobiles
Wed, Mar 31, 2021

The disruption of supply chains has created a shortage of chips, forcing automobile makers to slow down production. How does the global chipmaking industry work, and how did similar shocks play out earlier?

Explained: Why India’s crude oil price could rise following blockage of Suez Canal
Tue, Mar 30, 2021

The biggest impact on the oil trade and crude prices will be if the freeing of the container ship ‘Ever Given’ takes weeks, as is now being predicted. The longer the closure, the more disruptive the impact is likely to be.

One year since lockdown 1.0: Services sector distress means journeys of hope are cut short
Thu, Mar 25, 2021

Each distress story in India’s services sector is unique but all of them face similar questions: The lockdown may have eased but when will demand pick up? What happens with a second Covid wave?

One year since lockdown 1.0: Share in workforce already falling, Covid-19 job losses hit women harder
Thu, Mar 25, 2021

From Gurugram to Srirangapatna, the Covid-19 pandemic and the lockdown-induced economic distress deepened a structural problem that India’s labour market was already witnessing -- participation of women in the workforce.

Advertisement
Advertisement
Advertisement
Advertisement